Although non-coronary artery bypass graft ( CABG ) TIMI major bleeding was increased with prasugrel as compared with clopidogrel ( HR @ , @ % CI @-@ @ , p = @ ) , there was a net clinical benefit in patients assigned to prasugrel ( HR @ , @ % CI @-@ @ , p = @ ) , which was consistent for UA and NSTEMI subgroups ( interaction p value = @ and @ ) .